Dr Reddys Laboratories (RDY) Work In Process (2009 - 2017)

Dr Reddys Laboratories (RDY) posted Work In Process of $108.1 million for Q4 2017, up 1.15% on a QoQ basis from $106.8 million in Q3 2017.

Analysis

Dr Reddys Laboratories (RDY) Work In Process (2009 - 2017) Analysis & Trends

Dr Reddys Laboratories has reported Work In Process for 3 years, with the latest figure at $108.1 million in Q4 2017.

On a quarterly basis, Work In Process changed N/A year-over-year to $108.1 million in Q4 2017; TTM through Dec 2017 was $108.1 million, a N/A change from a year earlier, with the FY2017 full-year figure at $98.7 million, changed N/A from the prior year.
Work In Process was $108.1 million for Q4 2017 at Dr Reddys Laboratories, up from $106.8 million in the prior quarter.
The five-year high for Work In Process was $130.4 million in Q4 2014, with the low at $98.8 million in Q1 2017.

Peer Set

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Teva Pharmaceutical Industries	42.34 Bn	38.68 Bn	2.15 Bn
2	Viatris	19.39 Bn	18.50 Bn	1.46 Bn
3	Dr Reddys Laboratories	9.99 Bn	9.85 Bn	396.53 Mn
4	Amneal Pharmaceuticals	5.57 Bn	5.53 Bn	334.51 Mn
5	Bausch Health Companies	2.45 Bn	1.58 Bn	2.10 Bn
6	Ani Pharmaceuticals	1.70 Bn	1.34 Bn	165.89 Mn
7	Alvotech	1.66 Bn	1.52 Bn	2.56 Mn
8	Amphastar Pharmaceuticals	985.90 Mn	695.77 Mn	93.47 Mn
9	Fennec Pharmaceuticals	434.07 Mn	392.82 Mn	17.15 Mn
10	NutriBand	72.57 Mn	69.15 Mn	181,874.00

Historic Data

Download Data